Updated:
Avtar Investments
Avtar Investments manages Patel family capital from Amneal Pharmaceuticals across healthcare and technology holdings.
Avtar Investments
Chirag and Chintu Patel formed Avtar Investments in 2013 after building Amneal Pharmaceuticals from a small generics company founded in 2002. Their father Kanubhai Patel, an industrial pharmacist, advised the family through the immigration from India in 1987 and the subsequent growth of the pharmaceutical business. The office now manages capital generated by that success and by additional family enterprises. Avtar pursues direct co-investments, SPVs and private equity positions in biopharmaceuticals, health technology and mobility. It has deployed more than $1B of family capital from early-stage startups through commercialization. Confirmed holdings include real-estate assets such as Abbotsford Real Estate Holdings in British Columbia and Harrison Encore Lot 12 in Tampa, alongside leased industrial facilities tied to Amneal. The geographic footprint centers on North America with additional exposure in Oceania. The firm maintains a team led by CEO and CIO Raj Alva, formerly of New Mountain Capital. An additional office operates in Bridgewater, New Jersey. Avtar supports philanthropic vehicles including the Liberty Science Center, where Chirag Patel serves as Managing Trustee, and the Make-a-Wish Foundation, where Chintu Patel sits on the board. No material operational events have been recorded in the last 24 months. Avtar’s structure embeds operating-company experience directly into investment decisions. The Patel family’s control of Amneal and related manufacturing assets supplies proprietary sourcing and post-investment operational support that typical financial sponsors lack.
General information
Firm type
Single Family Office
Year founded
2013
AUM
$1B (Altss estimate)
Location
Region
North America
Country
United States
City
Palm Beach Gardens
Corporate office
11300 US Highway 1, Suite 209, Palm Beach Gardens, FL 33408, United States
Additional offices
Bridgewater, NJ, United States
Principals
Chirag Patel
Founder and Chairman
Chintu Patel
Founder and Co-Chairman
Altss tracks 2 additional named team members for this firm — including direct investment leads, IR, and operating principals not listed on the public website.
Book a demoSector focus
Frequently asked questions
Who runs investment decisions at Avtar Investments?
Raj Alva serves as CEO and CIO. Chirag Patel acts as Chairman and Chintu Patel as Co-Chairman, with Kanubhai Patel providing operational and strategic advice.
How does Avtar Investments source proprietary deal flow?
The firm draws on the Patel family’s operating experience at Amneal Pharmaceuticals and related businesses. Direct relationships with entrepreneurs and co-investors supplement this channel.
Does Avtar Investments participate in fund commitments or only direct deals?
Avtar executes both direct co-investments through SPVs and commitments to external funds. The mix reflects its stated preference for flexible capital across company life cycles.
What investment stages does Avtar Investments typically target?
The firm invests from early-stage startups through commercialization and industry leadership. It explicitly avoids the need for repeated capital raises by providing long-term support.
Where does the underlying wealth come from?
Wealth originates from the Patel family’s founding and growth of Amneal Pharmaceuticals, a generics and specialty drug company, plus subsequent investments in biotech and health technology.
Does Avtar Investments maintain philanthropic structures?
Yes. The family supports the Liberty Science Center, Make-a-Wish Foundation, Irada Foundation and several educational institutions. These vehicles operate separately from the investment office.
What is Avtar Investments’ known posture on co-investments alongside external GPs?
Avtar routinely joins co-investments and club deals. It has partnered with TPG on Amneal-related matters and with other family offices on real-estate and infrastructure platforms.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: